Quantitative Advantage’s Aptus Defined Risk ETF DRSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$4.61M Buy
177,422
+4,849
+3% +$125K 0.67% 41
2022
Q4
$4.42M Buy
172,573
+10,250
+6% +$263K 0.68% 43
2022
Q3
$4.12M Buy
+162,323
New +$4.31M 0.72% 41

Other funds holding DRSK

Quantitative Advantage's DRSK Position: Q1 2023 in Review

Quantitative Advantage increased its Aptus Defined Risk ETF (DRSK) stake by 2.8% in Q1 2023, buying an estimated $125K and bringing the position to 177,422 shares worth $4.61M. The position accounts for 0.67% of the portfolio, ranked #41.

Quantitative Advantage first reported a position in DRSK in Q3 2022 and has held it in 3 quarters since. 62 funds tracked by Wall St. Rank hold DRSK as of Q1 2023.

  • Quantitative Advantage held 177,422 shares of Aptus Defined Risk ETF worth $4.61M as of Q1 2023.
  • Quantitative Advantage bought 4,849 Aptus Defined Risk ETF shares in Q1 2023, an estimated $125K.
  • Aptus Defined Risk ETF made up 0.67% of Quantitative Advantage's portfolio in Q1 2023, its #41 holding.
  • Quantitative Advantage first reported a position in Aptus Defined Risk ETF in Q3 2022 and has held it in 3 quarters since.
  • 62 funds tracked by Wall St. Rank held Aptus Defined Risk ETF as of Q1 2023.

Based on Quantitative Advantage's 13F filing for Q1 2023, filed 12 May 2023.